Evidence map›Paper›PMID 40514007›Full record

ArticleNeuropharmacology2025

Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors.

Jazmine D W Yaeger, Megan M John, Leighton J Ledesma, Kevin T Krupp, Clarissa D Booth, Nathan T Jones, Aisel Valiño, Nathan Popp, Monica Sathyanesan, Samuel S Newton and 1 more

Abstract read
In one paragraph

Article in Neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jazmine D W YaegerCellular Therapies and Stem Cell Biology Group, Sanford Research, Sioux Falls, SD, 57104, USA.
Megan M JohnDepartment of Biology, University of South Dakota, Vermillion, SD, 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine University of South Dakota, Vermillion, SD, 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System Sioux Falls, SD, 57105, USA.
Leighton J LedesmaIDP in Biomedical Sciences, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Kevin T KruppDepartment of Biology, University of South Dakota, Vermillion, SD, 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine University of South Dakota, Vermillion, SD, 57069, USA.
Clarissa D BoothPediatrics and Rare Diseases Group, Sanford Research, 2301 E. 60th St. N., Sioux Falls, SD, 57104, USA.
Nathan T JonesDepartments of Molecular Pharmacology and Experimental Therapeutics and Psychiatry and Psychology, Mayo Clinic, Rochester, MN, 55902, USA.
Aisel ValiñoDepartment of Biology, University of South Dakota, Vermillion, SD, 57069, USA.
Nathan PoppDepartment of Biology, University of South Dakota, Vermillion, SD, 57069, USA.
Monica SathyanesanNeuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine University of South Dakota, Vermillion, SD, 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System Sioux Falls, SD, 57105, USA.
Samuel S NewtonNeuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine University of South Dakota, Vermillion, SD, 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System Sioux Falls, SD, 57105, USA.
Cliff H SummersDepartment of Biology, University of South Dakota, Vermillion, SD, 57069, USA; Neuroscience Group, Division of Basic Biomedical Sciences, Sanford School of Medicine University of South Dakota, Vermillion, SD, 57069, USA; Veterans Affairs Research Service, Sioux Falls VA Health Care System Sioux Falls, SD, 57105, USA. Electronic address: cliff@usd.edu.

Funding

The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI EGLAND, KRISTI A · 2012 to 2020
$20.8M
Trophic Factors in CognitionR01MH106640 · NIMH · UNIVERSITY OF SOUTH DAKOTA · PI SATHYANESAN, SAMUEL NEWTON · 2016 to 2025
$3.7M
Sex Differences in the Neurobiological Significance of Orexin Stress SignalingR15MH125306 · NIMH · UNIVERSITY OF SOUTH DAKOTA · PI SUMMERS, CLIFF H · 2021 to 2021
$427k
Amygdalar Orexin Modulation of Affective DisordersR15MH104485 · NIMH · UNIVERSITY OF SOUTH DAKOTA · PI SUMMERS, CLIFF H · 2015 to 2015
$426k
NIGMS NIH HHS P20 GM103548NIMH NIH HHS R01 MH106640NIMH NIH HHS R15 MH104485NIMH NIH HHS R15 MH125306
6 · The paper itself

Abstract

The hormone and trophic factor Erythropoietin (EPo) promotes red blood cell production and has neurotrophic effects, modulating behavior and promoting neural plasticity, like neurogenesis. Modifying EPo by attaching a carbamoyl group (cEPo) results in similar neuronal effects without erythropoietic actions. We hypothesize that neuroplastic and learning effects of cEPo may be dependent on its action in dorsal dentate gyrus of the hippocampus, where neurogenesis occurs. The Stress Alternatives Model (SAM) is a 4-day social stress and decision-making paradigm with a large novel aggressor that provides opportunities to avoid interaction via escape routes. Early, male test mice display stable Escape (avoiding aggression) or Stay (acquiescence to aggressor) behavioral phenotypes. In these studies, mice were given a single intracerebroventricular (icv; 100 ng), or single intra-dentate gyrus (iDG; 10 ng) injection of cEPo or vehicle. By Day 4, 30% of icv cEPo treated mice and 37.5% of iDG cEPo treated mice reversed their phenotype (Stay to Escape). Mice receiving vehicle injections did not change. Normalization of social preference, and reduction in fear freezing behavior, after cEPo treatment, coincide with transcriptional changes of orexin receptors (Hcrtr

Indexed as

AnxietyDepressionErythropoietinStress, PsychologicalAnimalsDentate GyrusFearHippocampusMaleMiceMice, Inbred C57BLSocial Behaviorcarbamylated erythropoietinErythropoietin

Identifiers

PMID40514007
PMCPMC12258813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.